Aaron Gebrelul, MD
Adult Reconstructive Orthopaedic Surgery · Arlington, VANPI 1497119358
Payments from drug & device makers
What this record shows
This record is dominated by education: $15,000 of the $20,809 with a category attached, or 72.1%. Smith+Nephew accounts for 72.2% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2022 at $12,062 and has fallen 99.4% since, to $75 in 2025.
Across 36 payments — averaging $578.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$15K
- Stryker$4K
- Encore Medical, LP$2K
- Heron Therapeutics, Inc.$125
- Pylant Medical$67
- Takeda Pharmaceuticals U.S.A., Inc.$18
What the payments were for
- Travel & lodging$3,86519%
- Food & beverage$1,9449%
- Education$15,00072%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 3 | $15,022 |
| Stryker | 21 | $3,711 |
| Encore Medical, LP | 9 | $1,866 |
| Heron Therapeutics, Inc. | 1 | $125 |
| Pylant Medical | 1 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$20,809 in reported general payments places this provider in the 70th percentile of 58 adult reconstructive orthopaedic surgery providers in Virginia.
See all adult reconstructive orthopaedic surgery providers in Virginia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 212 | $5,791 |
| Ondansetron OdtOndansetron | 93 | $637 |
| Oxycodone Hcl | 111 | $535 |
| Tramadol Hcl | 139 | $429 |
| Cefadroxil | 78 | $298 |
| Gabapentin | 29 | $216 |
| Meloxicam | 25 | $64 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Arlington
- Nitin GoyalArlington$81.5M
- Charles EnghArlington$5.5M
- Robert SershonArlington$94K
- Kurtis CarlockArlington$16K
- Jacob ZalewskiArlington$7K
- Charles EnghArlington$4K
- Nigel AzerArlington$412
- Andrew HolmesArlington$24
- William HamiltonAlexandria$9.3M
- James BrowneCharlottesville$4.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.